BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 26521103)

  • 1. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries.
    Takahashi S; Betsuyaku T
    Respir Investig; 2015 Nov; 53(6):259-70. PubMed ID: 26521103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity in chronic obstructive pulmonary disease.
    Negewo NA; McDonald VM; Gibson PG
    Respir Investig; 2015 Nov; 53(6):249-58. PubMed ID: 26521102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comorbidities in COPD: a new challenge in clinical practice].
    Couillard A; Veale D; Muir JF
    Rev Pneumol Clin; 2011 Jun; 67(3):143-53. PubMed ID: 21665077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidities of chronic obstructive pulmonary disease.
    Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.
    Corlateanu A; Covantev S; Mathioudakis AG; Botnaru V; Siafakas N
    Respir Investig; 2016 Nov; 54(6):387-396. PubMed ID: 27886849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comorbidities in COPD].
    de Miguel Díez J; García TG; Maestu LP
    Arch Bronconeumol; 2010 Dec; 46 Suppl 11():20-5. PubMed ID: 21316557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.
    Park HJ; Leem AY; Lee SH; Song JH; Park MS; Kim YS; Kim SK; Chang J; Chung KS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1571-82. PubMed ID: 26300636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
    Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of comorbidities in COPD patients by disease severity in a German population.
    Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
    Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease and comorbidities.
    Decramer M; Janssens W
    Lancet Respir Med; 2013 Mar; 1(1):73-83. PubMed ID: 24321806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comorbidities of COPD].
    Brinchault G; Diot P; Dixmier A; Goupil F; Guillais P; Gut-Gobert C; Leroyer C; Marchand-Adam S; Meurice JC; Morel H; Person C; Cavaillès A
    Rev Pneumol Clin; 2015 Dec; 71(6):342-9. PubMed ID: 26585876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes.
    Martinez CH; Han MK
    Med Clin North Am; 2012 Jul; 96(4):713-27. PubMed ID: 22793940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic manifestations of COPD.
    Nussbaumer-Ochsner Y; Rabe KF
    Chest; 2011 Jan; 139(1):165-73. PubMed ID: 21208876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease comorbidities.
    Brown JP; Martinez CH
    Curr Opin Pulm Med; 2016 Mar; 22(2):113-8. PubMed ID: 26814720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
    Bernardo I; Bozinovski S; Vlahos R
    Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell senescence and pathophysiology of chronic lung diseases: role in chronic obstructive pulmonary disease].
    Adnot S
    Bull Acad Natl Med; 2014; 198(4-5):659-71. PubMed ID: 26753399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.